Slope estimate (SEM) | P value | |
Time from enrolment (per visit follow-up) | −0.23±0.03 | <0.001 |
Randomisation to MAP/CB-CAPs testing arm | −0.174±0.080 | 0.030 |
Positive MAP/CB-CAPs test results | +0.311±0.116 | 0.008 |
CB-CAPs, cell-bound complement activation products; MAP, multianalyte assay panel.